The Electronic Telegraph
Wednesday 29 October 2003
Tom Knight


The focus in the escalating American doping scandal shifted to Dwain
Chambers's coach, Remi Korchemny, yesterday, as yet another of his athletes
was reported to have tested positive for a banned substance.
According to the Washington Post the American sprinter Chryste Gaines is the
latest athlete to have tested positive for the stimulant, modafinil.
Istvan Gyulai, generalsecretary of the International Association of
Athletics Federations, said Korchemny could become the first coach to face
sanctions - possibly a life ban - in a doping case.
It is understood modafinil was found in the urine sample provided by Gaines
at the US Championships in June. The samples collected at those
championships were recently retested when the US Anti-Doping Agency
uncovered the existence of a new, designer steroid called
tetrahydrogestrinone, or THG.
Gaines, 33, who enjoyed a late run of form during the season to win the 100
metres at the World Athletics Finals in Monte Carlo, would be the fourth
athlete connected to Korchemny to have failed a drugs test.
Chambers has tested positive for THG and the Americans Kelli White, Chris
Phillips and Calvin Harrison for modafinil, a drug banned by the IAAF
because it is categorised as being related to the family of stimulants.
Phillips and Harrison said they were given modafinil by Korchemny. Phillips,
who along with White tested positive at the World Championships, told the
IAAF that he was given the drug just before his 110m hurdles semi-final.
Gyulai said: "If what Phillips said is true, we will investigate because it
is unacceptable for coaches to encourage athletes to take prohibited
substances."
Robert Wagner, Phillips's agent, said: "Everybody is taking something to be
alert and awake. I've seen sprinters drink lots of coffee because it makes
you sharper."
Korchemny remained defiant. He said: "Modafinil is the same as aspirin or
coffee - big deal. It was not on the list of banned substances."

Eamonn Condon
[EMAIL PROTECTED]

Reply via email to